As presented by Xu P. et al. [81], HDAC2 is required for the chromatin remodeling of IFNγ-induced PD-L1 expression in breast tumors, and direct HDAC2 targeting suppresses immune escape of the tumor. The gene discussed is CD274; the disease is breast neoplasm.